ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Pgam5-mediated PHB2 dephosphorylation contributes to endotoxemia-induced myocardial dysfunction by inhibiting mitophagy and the mitochondrial unfolded protein response

Cai, Chen; Li, Ziying; Zheng, Zemao; Guo, Zhongzhou; Li, Qian; Deng, Shuxian; Shi, Nengxian; Ou, Qing; Zhou, Hao; Guo, Zhigang; Chen, Zhongqing*; Zhu, Hang*广州医学院; 南方医科大学; 6; 1
International Journal of Biological Sciences2023DOI: 10.7150/ijbs.85767
8阅读
引用收藏
分享

摘要

Numerous mitochondrial abnormalities are reported to result from excessive inflammation during endotoxemia. Prohibitin 2 (PHB2) and phosphoglycerate mutase 5 (Pgam5) have been associated with altered mitochondrial homeostasis in several cardiovascular diseases; however, their role in endotoxemia-related myocardial dysfunction has not been explored. Our experiments were aimed to evaluate the potential contribution of Pgam5 and PHB2 to endotoxemia-induced mitochondrial dysfunction in cardiomyocytes, with a focus on two endogenous protective programs that sustain mitochondrial integrity, namely mitophagy and the mitochondrial unfolded protein response (UPRmt). We found that PHB2 transgenic mice are resistant to endotoxemia-mediated myocardial depression and mitochondrial damage. Our assays indicated that PHB2 overexpression activates mitophagy and the UPRmt, which maintains mitochondrial metabolism, prevents oxidative stress injury, and enhances cardiomyocyte viability. Molecular analyses further showed that Pgam5 binds to and dephosphorylates PHB2, resulting in cytosolic translocation of mitochondrial PHB2. Silencing of Pgam5 or transfection of a phosphorylated PHB2 mutant in mouse HL-1 cardiomyocytes prevented the loss of mitochondrially-localized PHB2 and activated mitophagy and UPRmt in the presence of LPS. Notably, cardiomyocyte-specific deletion of Pgam5 in vivo attenuated LPS-mediated myocardial dysfunction and preserved cardiomyocyte viability. These findings suggest that Pgam5/PHB2 signaling and mitophagy/UPRmt are potential targets for the treatment of endotoxemia-related cardiac dysfunction.

学科与关键词

关键词
Pgam5PHB2endotoxemia-related cardiac dysfunction
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
International Journal of Biological Sciences
发表日期
2023
卷期
第 19 卷, 第 14 期
页码
4657-4671
DOI
10.7150/ijbs.85767
语言
ENGLISH
成果收录
SCIE
资助标注
NSFC [82170241, 82270279, 82200296]

作者

  • C

    Cai, Chen (第一作者)

    1 · southern med univ

  • L

    Li, Ziying

    1 · southern med univ

查看全部 12 位作者收起作者
  • Z

    Zheng, Zemao

    southern med univ

  • G

    Guo, Zhongzhou

  • L

    Li, Qian

    2 · guangzhou med univ

  • D

    Deng, Shuxian

    1 · southern med univ

  • S

    Shi, Nengxian

    1 · southern med univ

  • O

    Ou, Qing

    1 · southern med univ

  • Z

    Zhou, Hao

  • G

    Guo, Zhigang

  • C

    Chen, Zhongqing (通讯)

    southern med univ

  • Z

    Zhu, Hang (通讯)

    6 · peoples liberat army gen hosp

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417